Albert Einstein College of Medicine
Bronx, NY
Dr. Mansoor M. Ahmed received his Ph.D. from the University of Madras in Environmental Toxicology, studying cytogenetics and molecular biology of pesticide-induced myelodysplastic syndrome in farmers from South India. He then had 18 months of training as a Monbusho Scholar at the Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan, where he studied the molecular biology of Non-Hodgkin’s lymphoma and T-cell leukemia in A-bomb survivors. Dr. Ahmed studied the micro-dissection of chromosomes in solid tumors and radiation-induced signal transduction during his post-doctoral training at Thomas Jefferson University in Pennsylvania and the University of Kentucky. His first faculty position was at the University of Kentucky, Department of Radiation Medicine. After his tenure at the University of Kentucky, Dr. Ahmed joined Weis Center for Research, Geisinger Clinic, and, later, the University of Miami, Department of Radiation Oncology, where he established programs in Molecular Radiation Biology. At all three centers, he taught Mammalian Radiation Biology for radiation oncology residents.
His primary interest is in the best way to apply radiation fractionation schemes from a mechanistic standpoint. His translational, pre-clinical research on low-dose radiation as a chemo-potentiator resulted in novel clinical protocols for head and neck, lung, ovarian, and pancreatic cancers. More recently, his group has described seminal mechanistic findings on bystander signal transduction pathways in response to high-dose ablative radiotherapy. This was translated into clinics that were using Lattice radiotherapy in several solid tumors. During his career, he has had more than 150 peer-reviewed publications with several invited reviews and chapters.
Disclosures:
Tuesday, October 1, 2024
4:00 PM – 5:00 PM ET
Tuesday, October 1, 2024
4:00 PM – 4:02 PM ET
Preclinical Foundations: Ensuring Quality and Relevance for Clinical Trials
Tuesday, October 1, 2024
4:02 PM – 4:17 PM ET
Tuesday, October 1, 2024
4:47 PM – 5:00 PM ET